Key Takeaways
- • Thrive Capital's 2022 early-stage fund grew sevenfold from its $516 million initial commitment to approximately $3.7 billion, driven primarily by early stakes in OpenAI, SpaceX, and Anduril, according to CEO Josh Kushner's investor letter.
- • Thrive invested roughly $1 billion in OpenAI at a $285 billion valuation in December 2025, securing a significant position in one of the most valuable AI companies, with the firm subsequently participating in additional OpenAI fundraising rounds.
- • OpenAI's valuation has escalated substantially since Thrive's investment, with the company raising $8.3 billion in a tender offer that pushed its valuation to levels significantly higher than the $285 billion entry price, providing substantial unrealized gains.
- • Thrive Capital is raising a new $10 billion fund, signaling aggressive expansion of the firm's venture capital operations on the back of outsized returns from its AI and deep-tech portfolio concentration.
- • The fund demonstrates exceptional portfolio construction, with major positions across OpenAI, Stripe, Databricks, Cursor, and Anduril, providing exposure to both generative AI infrastructure and autonomous systems.
Summary
Thrive Capital's 2022 early-stage venture fund has delivered exceptional returns, growing sevenfold from its initial $516 million commitment to approximately $3.7 billion in valuation, according to a recent investor letter disclosed by CEO Josh Kushner. The outsized performance reflects a concentrated bet on artificial intelligence and emerging deep-tech companies that have subsequently achieved unicorn or mega-unicorn status.
The fund's most significant holding is OpenAI, where Thrive invested roughly $1 billion at a $285 billion valuation in December 2025. This investment positioned Thrive as a lead investor in OpenAI's most recent funding activities. Notably, OpenAI has subsequently raised an additional $8.3 billion through a tender offer process, pushing the company's valuation substantially higher and generating significant paper gains for early investors like Thrive.
Beyond OpenAI, Thrive's portfolio includes major positions in SpaceX, Anduril, Stripe, Databricks, and Cursor—representing a strategic concentration in AI infrastructure, autonomous systems, and developer-focused software platforms. This portfolio composition has proven highly valuable given the market's intense focus on generative AI capability and enterprise adoption. The letter reveals that Kushner's firm is capitalizing on these returns by raising a new $10 billion fund, substantially larger than the 2022 vehicle, to sustain its venture capital momentum.
The 2022 fund's 7x multiple in approximately three years underscores both the exceptional performance of Thrive's initial OpenAI thesis and the broader venture capital tailwinds in AI-adjacent sectors. For institutional investors and family offices evaluating early-stage venture exposure, Thrive's returns demonstrate the outsized value creation possible through concentrated positions in transformational AI companies during the early stages of their growth trajectories.
The fund's most significant holding is OpenAI, where Thrive invested roughly $1 billion at a $285 billion valuation in December 2025. This investment positioned Thrive as a lead investor in OpenAI's most recent funding activities. Notably, OpenAI has subsequently raised an additional $8.3 billion through a tender offer process, pushing the company's valuation substantially higher and generating significant paper gains for early investors like Thrive.
Beyond OpenAI, Thrive's portfolio includes major positions in SpaceX, Anduril, Stripe, Databricks, and Cursor—representing a strategic concentration in AI infrastructure, autonomous systems, and developer-focused software platforms. This portfolio composition has proven highly valuable given the market's intense focus on generative AI capability and enterprise adoption. The letter reveals that Kushner's firm is capitalizing on these returns by raising a new $10 billion fund, substantially larger than the 2022 vehicle, to sustain its venture capital momentum.
The 2022 fund's 7x multiple in approximately three years underscores both the exceptional performance of Thrive's initial OpenAI thesis and the broader venture capital tailwinds in AI-adjacent sectors. For institutional investors and family offices evaluating early-stage venture exposure, Thrive's returns demonstrate the outsized value creation possible through concentrated positions in transformational AI companies during the early stages of their growth trajectories.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.